Albrecht, Wiebke
Kappenberg, Franziska
Brecklinghaus, Tim
Stoeber, Regina
Marchan, Rosemarie
Zhang, Mian
Ebbert, Kristina
Kirschner, Hendrik
Grinberg, Marianna
Leist, Marcel
Moritz, Wolfgang
Cadenas, Cristina
Ghallab, Ahmed
Reinders, Jörg
Vartak, Nachiket
van Thriel, Christoph
Golka, Klaus
Tolosa, Laia
Castell, José V.
Damm, Georg
Seehofer, Daniel
Lampen, Alfonso
Braeuning, Albert
Buhrke, Thorsten
Behr, Anne-Cathrin
Oberemm, Axel
Gu, Xiaolong
Kittana, Naim
van de Water, Bob
Kreiling, Reinhard
Fayyaz, Susann
van Aerts, Leon
Smedsrød, Bård
Ellinger-Ziegelbauer, Heidrun
Steger-Hartmann, Thomas
Gundert-Remy, Ursula
Zeigerer, Anja
Ullrich, Anett
Runge, Dieter
Lee, Serene M. L.
Schiergens, Tobias S.
Kuepfer, Lars
Aguayo-Orozco, Alejandro
Sachinidis, Agapios
Edlund, Karolina
Gardner, Iain
Rahnenführer, Jörg
Hengstler, Jan G.
Funding for this research was provided by:
BMBF (031L0045, 031LO119, 01EK1604A, 031L0021A)
EU (681002, 116030)
European Regional Development Fund (CP16/00097)
Article History
Received: 10 April 2019
Accepted: 22 May 2019
First Online: 27 June 2019
Compliance with ethical standards
:
: Marianna Grinberg, Wolfgang Moritz, Reinhard Kreiling, Susann Fayyaz, Heidrun Ellinger-Ziegelbauer, Thomas Steger-Hartmann, and Lars Kuepfer are employees of the companies listed under the affiliations. The parabens analysed in this study were obtained from Clariant Produkte (Deutschland) GmbH. Iain Gardner and Mian Zhang are employees of Certara UK Limited, a company that develops the pharmacokinetic software used in this study. No financial support was obtained from any of the involved companies.